Trial Profile
Community Oncology Setting Cost Analysis and Disease Outcomes of Taxane Use in Metastatic Breast Cancer.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 25 Nov 2013
Price :
$35
*
At a glance
- Drugs Paclitaxel (Primary) ; Docetaxel; Taxanes
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 18 Nov 2011 Actual end date (Feb 2011) added as reported by ClinicalTrials.gov.
- 18 Nov 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 27 Jul 2010 Planned end date changed from 1 May 2010 to 1 Aug 2010 as reported by ClinicalTrials.gov.